Newly prequalified Active Pharmaceutical Ingredient (API)
M
Application of reference-scaled criteria for AUC in bioequivalence studies conducted for submission to PQT/MED
M
WHO bioequivalence guidelines (TRS No.
First dolutegravir 5mg dispersible tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First darunavir/ritonavir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lab Liconsa’s ivermectin prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Naari’s levonorgestrel tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Panpharma’s oxytocin injection prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Tunggal’s medroxyprogesterone acetate depot injection prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Macleods’ dispersible sulfadoxine/pyrimethamine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: